MOTIVIS Trademark

Trademark Overview

On Wednesday, March 15, 2017, a trademark application was filed for MOTIVIS with the United States Patent and Trademark Office. The USPTO has given the MOTIVIS trademark a serial number of 87371892. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The MOTIVIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
motivis

General Information

Serial Number87371892
Word MarkMOTIVIS
Filing DateWednesday, March 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2019EXTENSION 4 GRANTED
Tuesday, September 10, 2019EXTENSION 4 FILED
Tuesday, September 10, 2019TEAS EXTENSION RECEIVED
Friday, July 5, 2019ASSIGNED TO EXAMINER
Saturday, March 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2019EXTENSION 3 GRANTED
Thursday, March 7, 2019EXTENSION 3 FILED
Thursday, March 7, 2019TEAS EXTENSION RECEIVED
Friday, September 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 5, 2018EXTENSION 2 GRANTED
Wednesday, September 5, 2018EXTENSION 2 FILED
Wednesday, September 5, 2018TEAS EXTENSION RECEIVED
Thursday, March 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 6, 2018EXTENSION 1 GRANTED
Tuesday, March 6, 2018EXTENSION 1 FILED
Tuesday, March 6, 2018TEAS EXTENSION RECEIVED
Tuesday, March 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 8, 2017ASSIGNED TO EXAMINER
Tuesday, March 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

motivis cancer treatment preparations pharmaceutical